95417 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups - in which the condensed system contains two hetero rings Peri-condensed systems
COMPOUND, COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE
#2ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#3IMPROVED PREPARATION METHOD FOR RUCAPARIB
#4PHARMACEUTICAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING DEPRESSION AND OTHER DISORDERS
#5TRICYCLIC COMPOUNDS AND USES THEREOF
#6ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#7MELANIN DERIVED FROM PALM POLLEN
#8LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND
#9CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#10HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS
#11Impact Resistant Material
#12POLYCYCLIC POLY(ADP-RIBOSE) POLYMERASE SELECTIVE INHIBITOR
#13ORGANIC LIGHT-EMITTING DEVICE
#14QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE
#15SOLID STATE FORMS OF RUCAPARIB TOSYLATE
#16NOVEL METHOD FOR PRODUCING RUCAPARIB THAT IS PARP INHIBITOR AND INTERMEDIATE THEREOF
#17PARP1 INHIBITORS
#18NOVEL ORGANIC ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#19Compounds that Inhibit Necroptosis and Their Preparation Methods
#20Electrical Component Comprising Date Fruit Derived Melanin
#21THERAPEUTIC COMPOUNDS
#22COMPOUNDS AND METHODS FOR MODULATING SPLICING
#23TRICYCLIC KINASE INHIBITORS AND USES THEREOF
#24COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT
#25HIGH ACTIVITY STING PROTEIN AGONIST
#26LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND
#27HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER
#28COMPOUND, PHOTOELECTRIC DEVICE, LIGHT ABSORPTION SENSOR, SENSOR EMBEDDED DISPLAY PANEL, AND ELECTRONIC DEVICE
#29HIGHLY ACTIVE STING PROTEIN AGONIST COMPOUND
#30FUSED CYCLIC COMPOUND AS WEE-1 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
#31PROCESS FOR THE PRODUCTION OF TETRAAMINOBIPHENOL MACROCYCLIC LIGANDS; AND NOVEL TETRAAMINOBIPHENOL MACROCYCLIC LIGANDS
#32Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereof
#33HETEROCYCLIC COMPOUNDS AS PAD INHIBITORS
#34ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#35PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY
#36PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY
#37Novel Pharmaceutical Intermediates and Methods for Preparing the Same
#38PEG-MODIFIED CYCLIC DIPEPTIDES
#39INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE FLUORESCENT EMITTERS FOR USE IN OLEDS
#40TRICYCLIC UBIQUITIN SPECIFIC PROTEASE 1 INHIBITOR AND USE THEREOF
#41ORGANIC COMPOUND, LIGHT ABSORPTION SENSOR, SENSOR-EMBEDDED DISPLAY PANEL, AND ELECTRONIC DEVICE
#42TRICYCLIC KINASE INHIBITORS AND USES THEREOF
#43TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY
#44ORGANIC COMPOUNDS, MIXTURES AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES
#45MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#46ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF
#47GRANZYME B DIRECTED IMAGING AND THERAPY
#48ORGANIC COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF
#49ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#50ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#51ORGANIC ELECTROLUMINESCENT APPARATUS
#52ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#53GRANZYME B DIRECTED IMAGING AND THERAPY
#54AMINO ACID-, PEPTIDE- AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
#55ORGANIC LIGHT-EMITTING DEVICE
#56ORGANIC LIGHT-EMITTING DEVICE
#57ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#58HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DIODE
#59ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#60MACROCYCLES AS FACTOR XIA INHIBITORS
#61Compound and organic light-emitting device comprising same
#62ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#63ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#64ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#65ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#66ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#67Organic Electroluminescent Element, Material for Organic Electroluminescent Element, Light Emitting Device, Display Device and Lighting Device Each Using Said Element, and Compound Used for Said Element
#68HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
#69ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#70METHODS AND MATERIALS FOR INCREASING OR MAINTAINING NICOTINAMIDE MONONUCLEOTIDE ADENYLYL TRANSFERASE-2 (NMNAT2) POLYPEPTIDE LEVELS
#71ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#72GRANZYME B DIRECTED IMAGING AND THERAPY
#73Acetamido-phenyltetrazole derivatives and methods of using the same
#74TRAPPING-FREE PARP INHIBITORS
#75USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER
#76TRICYCLIC COMPOUNDS AS STING AGONISTS, AND PREPARATION METHODS AND MEDICINAL USES THEREOF
#77Fused tricyclic heterocycle compounds and therapeutic uses thereof
#78IMPACT RESISTANT MATERIAL
#79Plurality of host materials and organic electroluminescent device comprising the same
#80Process for the production of tetraaminobiphenol macrocyclic ligands; and novel tetraaminobiphenol macrocyclic ligands
#81Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides
#82Pharmaceutical intermediates and methods for preparing the same
#83Solid state forms of rucaparib and of rucaparib salts
#84Modulators of STING (stimulator of interferon genes)
#85AMINE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME
#86ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS
#87ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#88Granzyme B directed imaging and therapy
#89Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#90COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#91TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES
#92Heterocyclic compounds as pad inhibitors
#93Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device
#94USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER
#95Processes for the preparation of pharmaceutically acceptable salts of (R)-Pirlindole and (S)-Pirlindole
#96Crystalline of camphorsulfonic acid salt of rucaparib and method of preparing of tricyclic compounds, rucaparib and crystalline of camphorsulfonic acid salt of rucaparib
#97Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy
#98Macrocycles as factor XIA inhibitors
#99Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity
#100Organic electroluminescence element and electronic device
#101ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#102Organic electroluminescent device
#103FUSED CYCLIC COMPOUND, AND PREPARATION METHOD AND USE THEREOF
#104SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE
#105Solid state forms of rucaparib and of rucaparib salts
#106Process for the production of tetraaminobiphenol macrocyclic ligands; and novel tetraaminobiphenol macrocyclic ligands
#107Organic electroluminescent element, compound, and light emitting device, display device and lighting system, using said element
#108HOST MATERIALS FOR ELECTROLUMINESCENT DEVICES
#109Organic electroluminescent compound and organic electroluminescent device comprising the same
#110Composition of matter for use in organic light-emitting diodes
#111Novel Pharmaceutical Intermediates and Methods for Preparing the Same
#112Heterocyclic compound and organic light-emitting element using same
#113Polymorphs of rucaparib camsylate and methods of making same
#114Dual inhibitors of PARP1 and CDK
#115Dual inhibitors of PARP1 and CDK
#116Organic semiconducting compounds comprising a tetraazapyrene core
#117Compound, organic electroluminescence device and electronic device
#118Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
#119TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES
#120Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
#121TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES
#122Organic electroluminescent materials and devices
#123Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#124Compound for organic-electric element, organic-electric element using same, and electronic device for same
#125HETERO-CONDENSED PHENYLQUINAZOLINES AND THEIR USE IN ELECTRONIC DEVICES
#126Anthelmintic compounds
#127Heterocyclic compound and organic electroluminescence device including the same
#128Heterocyclic compounds with dibenzazapine structures
#129Compound, organic electroluminescence device and electronic device
#130Compound for organic electronic element, organic electronic element using the same, and electronic device thereof
#1315-HTreceptor agonists and compositions and methods of use
#1326-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
#133Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity
#134Macrocycles as factor XIa inhibitors
#135Organic electroluminescent device; a charge transporting material for the organic electroluminescent device; and a luminescent device, a display device and a lighting system using the organic electroluminescent device
#136Delayed fluorescence material and organic light emitting device having the delayed fluorescence material
#137Tricyclic heterocyclic compounds useful as inhibitors of TNF
#138Substituted tricyclic heterocyclic compounds
#139Compositions and methods for treating mitochondrial diseases
#140Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
#141Plurality of host materials and organic electroluminescent device comprising the same
#142Macrocycles as factor XIa inhibitors
#143Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
#144Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer
#145Compound, organic electroluminescence device and electronic device
#146Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#147Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof
#1486-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD
#149Electroactive materials
#150HETEROARYL COMPOUNDS FOR KINASE INHIBITION
#151Oxime ester compound and photopolymerization initiator containing said compound
#152Process for obtaining optically active pirlindole enantiomers and salts thereof
#153Ethynyl derivatives
#154Tricyclic heterocycle derivatives having HIV replication inhibitory effect
#155Imidazopyrazinone derivatives
#156White light emitting material and method of preparation and uses thereof
#157Method for producing carboxylic acid anhydride, method for producing carboxylic imide, and method for manufacturing electrophotographic photosensitive member
#158Macrocycles as factor XIa inhibitors
#159COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
#160Organic electroluminescent device; a charge transporting material for the organic electroluminescent device; and a luminescent device, a display device and a lighting system using the organic electroluminescent device
#161Organic electroluminescent materials and devices
#1626-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
#163Heterocyclic compound and organic light-emitting element using same
#164Perylene-based semiconductors
#165Tricyclic oxazolidinone antibiotic compounds
#166Organic electroluminescent materials and devices
#167Heterocyclic compound and organic light-emitting element using same
#168Heterocyclic compound and organic light-emitting element using same
#169Heterocyclic compound and organic light-emitting element using same
#170Compositions and methods for treating mitochondrial diseases
#171ETHYNYL DERIVATIVES
#172Organic electroluminescence
#173Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#174Organic light emitting display device
#175Methods and kits using extended rhodamine dyes
#176Condensed cyclic compound and organic light emitting device including the same
#177Delayed fluorescence compound, and organic light emitting diode and display device using the same
#178Delayed fluorescence compound, and organic light emitting diode and display device using the same
#179Macrocycles as factor XIa inhibitors
#180Compound, organic optoelectronic element comprising same, and display device
#181Condensed-cyclic compound and organic light-emitting device including the same
#182Tricyclic quinoline and quinoxaline derivatives
#183Antibacterial oxadiazolone derivatives
#184Organic electroluminescent materials and devices
#185Cycloclavine and Derivatives Thereof for Controlling Invertebrate Pests
#186Condensed cyclic compound and organic light-emitting device including the same
#187Pyrimidine compounds for the treatment of cancer
#188Process for making zilpaterol
#189Flindersia alkaloids, derivatives and analogs: compositions and methods for producing the same
#190Materials for organic electroluminescent devices
#191Organic electroluminescent materials and devices
#192Substituted tricyclic benzimidazoles as kinase inhibitors
#193Macrocycles as factor XIa inhibitors
#194Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
#1956-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
#196Genes and processes for the production of clavine-type alkaloids
#197MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME
#198SUBSTITUTED TERRYLENE AND QUATERRYLENE DERIVATES AND USE AS SEMICONDUCTORS THEREOF
#199Material for organic electroluminescence device and organic electroluminescence device including the same
#200Material for organic electroluminescence device and organic electroluminescence device using the same
#201Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
#202Inhibitors of HCV NS5A
#203Fullerene derivative, and method of preparing the same
#204Macrocycles as factor XIa inhibitors
#205Synthesis of polycyclic alkaloids
#206Cyclic P1 linkers as factor XIa inhibitors
#207Tricyclic compound
#208COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL DISEASES
#209Materials for organic electroluminescent devices
#210Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element
#211Aromatic heterocyclic derivative, material for organic electroluminescent element, and organic electroluminescent element
#212Organic electroluminescence element
#2136-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
#214Organic electroluminescent element, material for organic electroluminescent element and light emitting device, display device, and illumination device, each employing organic electroluminescent element
#215Compound having PARP inhibitory activity
#216Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
#217Organic electroluminescent element, compound, and light emitting device, display device and lighting system, using said element
#218Macrocycles as factor XIa inhibitors
#219Pharmaceutical intermediates and methods for preparing the same
#220Pharmaceutical intermediates and methods for preparing the same
#221Pharmaceutical intermediates and methods for preparing the same
#222Compositions and methods for treatment of cancer
#223Methods and kits using extended rhodamine dyes
#224Cyclic P1 linkers as factor XIa inhibitors
#225Tricyclic oxazolidinone antibiotic compounds
#226Benzoimidazole-carboxylic acid amide derivatives as APJ receptor modulators
#227Tricyclic quinoline and quinoxaline derivatives
#228Tricyclic quinoline and quinoxaline derivatives
#229Imidazole carbonyl compound
#230Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
#231Organic electroluminescent device; a charge transporting material for the organic electroluminescent device; and a luminescent device, a display device and a lighting system using the organic electroluminescent device
#232Asymmetrically substituted anthrapyridazone derivatives as cytostatics
#233Tetraazaperopyrene compounds and their use as n-type semiconductors
#234Tetraazapyrene compounds and their use as N-type semiconductors
#235Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
#236Macrocyclic indoles as hepatitis C virus inhibitors
#237Tricyclic indole derivatives useful endothelial lipase inhibitors
#238SUBSTITUTED INDOLES, ANTIVIRAL ACTIVE COMPONENT, METHOD FOR PREPARATION AND USE THEREOF
#239alkaloids, derivatives and analogs: compositions and methods for producing the same
#240NOVEL PHARMACEUTICAL INTERMEDIATES AND METHODS FOR PREPARING THE SAME
#241Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
#242Compositions and methods for treatment of cancer
#243Polyplex gene delivery vectors
#244PROCESSES FOR MAKING ZILPATEROL AND SALTS THEREOF
#245Heterocyclic compound and organic light-emitting device containing the same
#246DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
#247Quinacridone derivative, and photoactive layer and photoelectric conversion device including same
#248CXCR3 receptor antagonists
#249Materials for organic electroluminescent devices
#250PARP inhibitor compounds, compositions and methods of use
#251Macrocycles as factor XIa inhibitors
#252COMPOUNDS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PARP
#253Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
#254Facile preparation of 4-substituted quinazolines and related heterocycles
#255Nuclear Hormone Receptor Modulators
#256ANTIVIRAL COMPOUNDS
#2575-HTreceptor modulators, methods of making, and use thereof
#258IAP BIR domain binding compounds
#259Compounds for the reduction of beta-amyloid production
#260Organic electroluminescence device
#261ANTIVIRAL THERAPEUTIC AGENTS
#262Methods and kits using extended rhodamine dyes
#263Fullerene derivatives
#264Indolo[3,2,1-jk]carbazole compound and organic light-emitting device containing the same
#265Process for making a crystalline zilpaterol salt
#266Macrocycles as factor XIa inhibitors
#267PURINE DERIVATIVES AS KINASE INHIBITORS
#268ORGANIC COMPOUNDS
#269Purine derivatives as kinase inhibitors
#270Tricyclic oxazolidinone antibiotic compounds
#271Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency
#2725,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)
#273ALKYNYL ALCOHOLS AS KINASE INHIBITORS
#274Methods and kits using extended rhodamine dyes
#275Heterocyclic compound and organic light-emitting device including the same
#276Selective agents for pain suppression
#277Imidazole carbonyl compound
#278Compounds with Antiparasitic Activity, Applications thereof to the Treatment of Infectious Diseases Caused by Apicomplexans
#279Macrocyclic indoles as hepatitis C virus inhibitors
#280HDAC Inhibitors
#281Compounds, methods and pharmaceutical compositions for inhibiting PARP
#282Triazole derivatives for treating alzheimer'S disease and related conditions
#283Compositions and methods for treatment of cancer
#284Tetrapeptide analogs
#285Compositions and methods for the treatment of cancer
#286Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one and zilpaterol
#287Tricyclic anilide spirolactam CGRP receptor antagonists
#288Tricyclic anilide heterocyclic CGRP receptor antagonists
#289ANTICONVULSANT AND ANXIOLYTIC METHODS OF USING RECEPTOR SUBTYPE SELECTIVE AGENTS
#290Processes for making zilpaterol and salts thereof
#291Fluorochromes for organelle tracing and multi-color imaging
#292Organic electroluminescence device
#293Zilpaterol enantiomer compositions and methods of making and using such compositions
#294STEREOSPECIFIC ANXIOLYTIC AND ANTICONVULSANT AGENTS WITH REDUCED MUSCLE-RELAXANT, SEDATIVE-HYPNOTIC AND ATAXIC EFFECTS
#295Compounds, methods and pharmaceutical compositions for inhibiting PARP
#296USE OF NEUROPROTECTIVE COMPOUNDS IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF NEURODEGENERATING DISEASES
#2975-HTreceptor modulators, methods of making, and use thereof
#298Antiviral therapeutic agents
#299Tricyclic anilide spirohydantion CGRP receptor antagonists
#300IAP BIR domain binding compounds